Gastrointestinal Therapeutics Market: By Drug Glass, By Mode of Administration, By Application, By Distribution Channel and Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Gastrointestinal Therapeutics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Drug Glass (Antacids, Laxatives, Antidiarrheal agents, Antiemetics, Antiulcer agents, and Others), By Mode of Administration (Oral, Intravenous, and Others), By Application (Gastroenteritis, Gastrointestinal Bleeding, Irritable Bowel Syndrome, and Peptic Ulcer Disease), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and others) and Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Gastrointestinal Therapeutics Market size was valued at US$ 53.8 billion in 2023, growing at a CAGR of 7.9% from 2024 to 2030. The global market provides a detailed overview of the market, and that can be segmented by drug, by mode of administration, by application, and by Distribution channel. By drug, the market has been segmented into antacids, Laxatives, Antidiarrheal agents, Antiemetics, Antiulcer agents, and Others. The Laxatives segment is likely to be the significant growing segment in drugs. Based on the Mode of administration, the market is segmented into Oral, Intravenous, and Others.

Among these, the Intravenous segment is expected to have the fastest-growing market during the forecast period 2022-2028. The considerable share is expected to be an outcome of the advantages related to IV products. It can also be due to the high price of IV products compared to oral care products. Based on the application, the market is segmented into Gastroenteritis, Gastrointestinal Bleeding, Irritable Bowel Syndrome, and Peptic Ulcer. The gastroenteritis gastrointestinal Bleeding segment is expected to have a significant share in 2021.

The rise of this segment is mainly because it offers an extensive range of applications for which gastrointestinal medicines have been used steadily over the prior years. Recurrent drug launches is also accountable for increased scope for development. Based on the Distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others. The Retail Pharmacies segment is expected to have a significant share in 2021. The rise of this segment is mainly because of the convenience and high affordability of retail stores. As the number of prescription drugs being compensated grows, it inspires patients to buy medicines from retail pharmacies. Retail pharmacists also endorse drug alternatives that avoid severe drug interactions.

Gastrointestinal Therapeutics Market Key Developments

  • In February 2021, in the United States, Lansoprazole delayed-release orally disintegrating tablets were launched by Dr. Reddy's Laboratories.
  • In March 2020, Sebela Pharmaceuticals got approval from the FDA for Pizensy (lactitol) for curing chronic idiopathic constipation (CIC) in adults.

summary download arrow Download Free Sample

Gastrointestinal Therapeutics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.9%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Gastrointestinal Therapeutics Market Dynimics

The growing incidence of gastrointestinal diseases is anticipated to propel the market growth over the forecast years. Moreover, the increasing clinical trials with promising results and increasing expenditure on healthcare are burgeoning the market growth over the forecast years.

Gastrointestinal Therapeutics Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 53.8 billion

Market CAGR

7.9%

By Drug Class

  • Antacids
  • Laxatives
  • Antidiarrheal agents
  • Antiemetics
  • Antiulcer agents
  • Others

By Mode Administration

  • Oral
  • Intravenous
  • Others

By Application

  • Gastroenteritis
  • Gastrointestinal Bleeding
  • Irritable Bowel Syndrome
  • Peptic Ulcer Disease

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • others

By Region

  • North America (USA, Canada)
  • Europe (Germany, UK, France, Spain, Italy , Rest of Europe)
  • The Asia Pacific (China, India, Japan, Australia, South Korea, Rest of Asia- Pacific)
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
  • MEA (Saudi Arabia, UAE, South Africa, Rest of MEA)

Key Features of the Report

  • The gastrointestinal therapeutics market report provides granular level information about the Market size, regional Market share, historic Market (2019-2023), and forecast (2024-2020)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key Market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the Market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the Market.
  • The report provides a plethora of information about Market entry strategies, regulatory framework, and reimbursement scenarios.
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The gastrointestinal therapeutics market size was valued at US$ 53.8 billion in 2023, growing at a CAGR of 7.9% from 2024 to 2030.

The market key players are: Abbott Laboratories (US) Allergan (Ireland) AstraZeneca plc (UK) GlaxoSmithKline Plc (UK) Takeda Pharmaceutical Company Limited (Japan) Pfizer Inc. (US) Bayer AG (Germany) Bausch Health (Canada) Merck & Co., Inc. (US) AbbVie Inc. (US)

The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Gastrointestinal Therapeutics Market Introduction 
2.1.Global Gastrointestinal Therapeutics Market  - Taxonomy
2.2.Global Gastrointestinal Therapeutics Market  - Definitions
2.2.1.Drug Class
2.2.2.Mode Administration
2.2.3.Application
2.2.4. Distribution Channel
2.2.5.Region
3. Global Gastrointestinal Therapeutics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Gastrointestinal Therapeutics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Gastrointestinal Therapeutics Market  By Drug Class, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Antacids
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Laxatives
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Antidiarrheal agents
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Antiemetics
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Antiulcer agents
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Others
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6. Global Gastrointestinal Therapeutics Market  By Mode Administration, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Oral
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Intravenous
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7. Global Gastrointestinal Therapeutics Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Gastroenteritis
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Gastrointestinal Bleeding
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Irritable Bowel Syndrome
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Peptic Ulcer Disease
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8. Global Gastrointestinal Therapeutics Market  By  Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Online Pharmacies
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. others
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9. Global Gastrointestinal Therapeutics Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Gastrointestinal Therapeutics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Drug Class Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Antacids
10.1.2.Laxatives
10.1.3.Antidiarrheal agents
10.1.4.Antiemetics
10.1.5.Antiulcer agents
10.1.6.Others
10.2.  Mode Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Oral
10.2.2.Intravenous
10.2.3.Others
10.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Gastroenteritis
10.3.2.Gastrointestinal Bleeding
10.3.3.Irritable Bowel Syndrome
10.3.4.Peptic Ulcer Disease
10.4.   Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospital Pharmacies
10.4.2.Retail Pharmacies
10.4.3.Online Pharmacies
10.4.4.others
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Gastrointestinal Therapeutics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Antacids
11.1.2.Laxatives
11.1.3.Antidiarrheal agents
11.1.4.Antiemetics
11.1.5.Antiulcer agents
11.1.6.Others
11.2.  Mode Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Oral
11.2.2.Intravenous
11.2.3.Others
11.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Gastroenteritis
11.3.2.Gastrointestinal Bleeding
11.3.3.Irritable Bowel Syndrome
11.3.4.Peptic Ulcer Disease
11.4.   Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospital Pharmacies
11.4.2.Retail Pharmacies
11.4.3.Online Pharmacies
11.4.4.others
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Gastrointestinal Therapeutics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Antacids
12.1.2.Laxatives
12.1.3.Antidiarrheal agents
12.1.4.Antiemetics
12.1.5.Antiulcer agents
12.1.6.Others
12.2.  Mode Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Oral
12.2.2.Intravenous
12.2.3.Others
12.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Gastroenteritis
12.3.2.Gastrointestinal Bleeding
12.3.3.Irritable Bowel Syndrome
12.3.4.Peptic Ulcer Disease
12.4.   Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospital Pharmacies
12.4.2.Retail Pharmacies
12.4.3.Online Pharmacies
12.4.4.others
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Gastrointestinal Therapeutics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Antacids
13.1.2.Laxatives
13.1.3.Antidiarrheal agents
13.1.4.Antiemetics
13.1.5.Antiulcer agents
13.1.6.Others
13.2.  Mode Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Oral
13.2.2.Intravenous
13.2.3.Others
13.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Gastroenteritis
13.3.2.Gastrointestinal Bleeding
13.3.3.Irritable Bowel Syndrome
13.3.4.Peptic Ulcer Disease
13.4.   Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospital Pharmacies
13.4.2.Retail Pharmacies
13.4.3.Online Pharmacies
13.4.4.others
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Gastrointestinal Therapeutics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Drug Class Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Antacids
14.1.2.Laxatives
14.1.3.Antidiarrheal agents
14.1.4.Antiemetics
14.1.5.Antiulcer agents
14.1.6.Others
14.2.  Mode Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Oral
14.2.2.Intravenous
14.2.3.Others
14.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Gastroenteritis
14.3.2.Gastrointestinal Bleeding
14.3.3.Irritable Bowel Syndrome
14.3.4.Peptic Ulcer Disease
14.4.   Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospital Pharmacies
14.4.2.Retail Pharmacies
14.4.3.Online Pharmacies
14.4.4.others
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Abbott Laboratories (US)
15.2.2.Allergan (Ireland)
15.2.3.AstraZeneca plc (UK)
15.2.4.GlaxoSmithKline Plc (UK)
15.2.5.Takeda Pharmaceutical Company Limited (Japan)
15.2.6.Pfizer Inc. (US)
15.2.7.Bayer AG (Germany)
15.2.8.Bausch Health (Canada)
15.2.9.Merck & Co., Inc. (US)
15.2.10.AbbVie Inc. (US)
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Abbott Laboratories (US)
  • Allergan (Ireland)
  • AstraZeneca plc (UK)
  • GlaxoSmithKline Plc (UK)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Pfizer Inc. (US)
  • Bayer AG (Germany)
  • Bausch Health (Canada)
  • Merck & Co., Inc. (US)
  • AbbVie Inc. (US)

Related Industry Reports

Gastrointestinal Infection Molecular Diagnostics Market

Gastrointestinal Molecular Diagnostics Market

Gastrointestinal Stents Market

Global Infectious Disease Therapeutics Market